Search

Your search keyword '"Bardin, Thomas"' showing total 972 results
Start Over Author "Bardin, Thomas"
972 results on '"Bardin, Thomas"'

1. A genome-wide association analysis reveals new pathogenic pathways in gout

Author

Major, Tanya J., Takei, Riku, Matsuo, Hirotaka, Leask, Megan P., Sumpter, Nicholas A., Topless, Ruth K., Shirai, Yuya, Wang, Wei, Cadzow, Murray J., Phipps-Green, Amanda J., Li, Zhiqiang, Ji, Aichang, Merriman, Marilyn E., Morice, Emily, Kelley, Eric E., Wei, Wen-Hua, McCormick, Sally P. A., Bixley, Matthew J., Reynolds, Richard J., Saag, Kenneth G., Fadason, Tayaza, Golovina, Evgenia, O’Sullivan, Justin M., Stamp, Lisa K., Dalbeth, Nicola, Abhishek, Abhishek, Doherty, Michael, Roddy, Edward, Jacobsson, Lennart T. H., Kapetanovic, Meliha C., Melander, Olle, Andrés, Mariano, Pérez-Ruiz, Fernando, Torres, Rosa J., Radstake, Timothy, Jansen, Timothy L., Janssen, Matthijs, Joosten, Leo A. B., Liu, Ruiqi, Gaal, Orsolya I., Crişan, Tania O., Rednic, Simona, Kurreeman, Fina, Huizinga, Tom W. J., Toes, René, Lioté, Frédéric, Richette, Pascal, Bardin, Thomas, Ea, Hang Korng, Pascart, Tristan, McCarthy, Geraldine M., Helbert, Laura, Stibůrková, Blanka, Tausche, Anne-K., Uhlig, Till, Vitart, Véronique, Boutin, Thibaud S., Hayward, Caroline, Riches, Philip L., Ralston, Stuart H., Campbell, Archie, MacDonald, Thomas M., Nakayama, Akiyoshi, Takada, Tappei, Nakatochi, Masahiro, Shimizu, Seiko, Kawamura, Yusuke, Toyoda, Yu, Nakaoka, Hirofumi, Yamamoto, Ken, Matsuo, Keitaro, Shinomiya, Nariyoshi, Ichida, Kimiyoshi, Lee, Chaeyoung, Bradbury, Linda A., Brown, Matthew A., Robinson, Philip C., Buchanan, Russell R. C., Hill, Catherine L., Lester, Susan, Smith, Malcolm D., Rischmueller, Maureen, Choi, Hyon K., Stahl, Eli A., Miner, Jeff N., Solomon, Daniel H., Cui, Jing, Giacomini, Kathleen M., Brackman, Deanna J., Jorgenson, Eric M., Liu, Hongbo, Susztak, Katalin, Shringarpure, Suyash, So, Alexander, Okada, Yukinori, Li, Changgui, Shi, Yongyong, and Merriman, Tony R.

Published
2024
Full Text
View/download PDF

2. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.

Author

Iagnocco, AnnaMaria, Lioté, Frédéric, McCarthy, Geraldine, Ramonda, Roberta, Richette, Pascal, Sivera, Francisca, Andrés, Mariano, Cipolletta, Edoardo, Doherty, Michael, Pascual, Eliseo, Perez-Ruiz, Fernando, So, Alexander, Jansen, Tim, Kohler, Minna, Stamp, Lisa, Yinh, Janeth, Adinolfi, Antonella, Arad, Uri, Aung, Thanda, Benillouche, Eva, Bortoluzzi, Alessandra, Dau, Jonathan, Maningding, Ernest, Fang, Meika, Figus, Fabiana, Filippucci, Emilio, Haslett, Janine, Janssen, Matthijs, Kaldas, Marian, Kimoto, Maryann, Leamy, Kelly, Navarro, Geraldine, Sarzi-Puttini, Piercarlo, Scirè, Carlo, Silvagni, Ettore, Sirotti, Silvia, Stack, John, Truong, Linh, Abhishek, Abhishek, Tedeschi, Sara, Pascart, Tristan, Latourte, Augustin, Dalbeth, Nicola, Neogi, Tuhina, Fuller, Amy, Rosenthal, Ann, Becce, Fabio, Bardin, Thomas, Ea, Hang-Korng, Filippou, Georgios, Yokose, Chio, Hendry, Alison, Terkeltaub, Robert, Taylor, William, Choi, Hyon, FitzGerald, John, and Xie, Chen

Subjects
Autoimmune Diseases, Immune Complex Diseases, Immune System Diseases, Humans, United States, Chondrocalcinosis, Rheumatology, Calcium Pyrophosphate, Calcinosis, Syndrome
Abstract

OBJECTIVE: Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have developed the first-ever validated classification criteria for symptomatic CPPD disease. METHODS: Supported by the ACR and EULAR, a multinational group of investigators followed established methodology to develop these disease classification criteria. The group generated lists of candidate items and refined their definitions, collected de-identified patient profiles, evaluated strengths of associations between candidate items and CPPD disease, developed a classification criteria framework, and used multi-criterion decision analysis to define criteria weights and a classification threshold score. The criteria were validated in an independent cohort. RESULTS: Among patients with joint pain, swelling, or tenderness (entry criterion) whose symptoms are not fully explained by an alternative disease (exclusion criterion), the presence of crowned dens syndrome or calcium pyrophosphate crystals in synovial fluid are sufficient to classify a patient as having CPPD disease. In the absence of these findings, a score>56 points using weighted criteria, comprising clinical features, associated metabolic disorders, and results of laboratory and imaging investigations, can be used to classify as CPPD disease. These criteria had a sensitivity of 92.2% and specificity of 87.9% in the derivation cohort (190 CPPD cases, 148 mimickers), whereas sensitivity was 99.2% and specificity was 92.5% in the validation cohort (251 CPPD cases, 162 mimickers). CONCLUSION: The 2023 ACR/EULAR CPPD disease classification criteria have excellent performance characteristics and will facilitate research in this field.

Published
2023

3. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.

Author

Abhishek, Abhishek, Tedeschi, Sara, Pascart, Tristan, Latourte, Augustin, Dalbeth, Nicola, Neogi, Tuhina, Fuller, Amy, Rosenthal, Ann, Becce, Fabio, Bardin, Thomas, Ea, Hang, Filippou, Georgios, Iagnocco, AnnaMaria, Lioté, Frédéric, McCarthy, Geraldine, Ramonda, Roberta, Richette, Pascal, Sivera, Francisca, Andres, Mariano, Cipolletta, Edoardo, Doherty, Michael, Pascual, Eliseo, Perez-Ruiz, Fernando, So, Alexander, Jansen, Tim, Kohler, Minna, Stamp, Lisa, Yinh, Janeth, Adinolfi, Antonella, Arad, Uri, Aung, Thanda, Benillouche, Eva, Bortoluzzi, Alessandra, Dau, Jonathan, Maningding, Ernest, Fang, Meika, Figus, Fabiana, Filippucci, Emilio, Haslett, Janine, Janssen, Matthijs, Kimoto, Maryann, Leamy, Kelly, Navarro, Geraldine, Sarzi-Puttini, Piercarlo, Scirè, Carlo, Silvagni, Ettore, Sirotti, Silvia, Stack, John, Truong, Linh, Yokose, Chio, Hendry, Alison, Terkeltaub, Robert, Taylor, William, Choi, Hyon, FitzGerald, John, Kaldas, Marian, and Xie, Chen

Subjects
Humans, Calcinosis, Calcium Pyrophosphate, Chondrocalcinosis, Rheumatology, Syndrome, United States
Abstract

OBJECTIVE: Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have developed the first-ever validated classification criteria for symptomatic CPPD disease. METHODS: Supported by the ACR and EULAR, a multinational group of investigators followed established methodology to develop these disease classification criteria. The group generated lists of candidate items and refined their definitions, collected de-identified patient profiles, evaluated strengths of associations between candidate items and CPPD disease, developed a classification criteria framework, and used multi-criterion decision analysis to define criteria weights and a classification threshold score. The criteria were validated in an independent cohort. RESULTS: Among patients with joint pain, swelling, or tenderness (entry criterion) whose symptoms are not fully explained by an alternative disease (exclusion criterion), the presence of crowned dens syndrome or calcium pyrophosphate crystals in synovial fluid are sufficient to classify a patient as having CPPD disease. In the absence of these findings, a score >56 points using weighted criteria, comprising clinical features, associated metabolic disorders, and results of laboratory and imaging investigations, can be used to classify as CPPD disease. These criteria had a sensitivity of 92.2% and specificity of 87.9% in the derivation cohort (190 CPPD cases, 148 mimickers), whereas sensitivity was 99.2% and specificity was 92.5% in the validation cohort (251 CPPD cases, 162 mimickers). CONCLUSION: The 2023 ACR/EULAR CPPD disease classification criteria have excellent performance characteristics and will facilitate research in this field.

Published
2023

4. Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout

Author

Major, Tanya J., Takei, Riku, Matsuo, Hirotaka, Leask, Megan P., Sumpter, Nicholas A., Topless, Ruth K., Shirai, Yuya, Wang, Wei, Cadzow, Murray J., Phipps-Green, Amanda J., Li, Zhiqiang, Ji, Aichang, Merriman, Marilyn E., Morice, Emily, Kelley, Eric E., Wei, Wen-Hua, McCormick, Sally P. A., Bixley, Matthew J., Reynolds, Richard J., Saag, Kenneth G., Fadason, Tayaza, Golovina, Evgenia, O’Sullivan, Justin M., Stamp, Lisa K., Dalbeth, Nicola, Abhishek, Abhishek, Doherty, Michael, Roddy, Edward, Jacobsson, Lennart T. H., Kapetanovic, Meliha C., Melander, Olle, Andrés, Mariano, Pérez-Ruiz, Fernando, Torres, Rosa J., Radstake, Timothy, Jansen, Timothy L., Janssen, Matthijs, Joosten, Leo A. B., Liu, Ruiqi, Gaal, Orsolya I., Crişan, Tania O., Rednic, Simona, Kurreeman, Fina, Huizinga, Tom W. J., Toes, René, Lioté, Frédéric, Richette, Pascal, Bardin, Thomas, Ea, Hang Korng, Pascart, Tristan, McCarthy, Geraldine M., Helbert, Laura, Stibůrková, Blanka, Tausche, Anne-K., Uhlig, Till, Vitart, Véronique, Boutin, Thibaud S., Hayward, Caroline, Riches, Philip L., Ralston, Stuart H., Campbell, Archie, MacDonald, Thomas M., Nakayama, Akiyoshi, Takada, Tappei, Nakatochi, Masahiro, Shimizu, Seiko, Kawamura, Yusuke, Toyoda, Yu, Nakaoka, Hirofumi, Yamamoto, Ken, Matsuo, Keitaro, Shinomiya, Nariyoshi, Ichida, Kimiyoshi, Lee, Chaeyoung, Bradbury, Linda A., Brown, Matthew A., Robinson, Philip C., Buchanan, Russell R. C., Hill, Catherine L., Lester, Susan, Smith, Malcolm D., Rischmueller, Maureen, Choi, Hyon K., Stahl, Eli A., Miner, Jeff N., Solomon, Daniel H., Cui, Jing, Giacomini, Kathleen M., Brackman, Deanna J., Jorgenson, Eric M., Liu, Hongbo, Susztak, Katalin, Shringarpure, Suyash, So, Alexander, Okada, Yukinori, Li, Changgui, Shi, Yongyong, and Merriman, Tony R.

Published
2024
Full Text
View/download PDF

5. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction.

Author

Tedeschi, Sara, Pascart, Tristan, Latourte, Augustin, Godsave, Cattleya, Kundakci, Burak, Naden, Raymond, Taylor, William, Dalbeth, Nicola, Neogi, Tuhina, Perez-Ruiz, Fernando, Rosenthal, Ann, Becce, Fabio, Pascual, Eliseo, Andres, Mariano, Bardin, Thomas, Doherty, Michael, Ea, Hang-Korng, Filippou, Georgios, Guitierrez, Marwin, Iagnocco, Annamaria, Jansen, Tim, Kohler, Minna, Lioté, Frédéric, Matza, Mark, McCarthy, Geraldine, Ramonda, Roberta, Reginato, Anthony, Richette, Pascal, Singh, Jasvinder, Sivera, Francisca, So, Alexander, Stamp, Lisa, Yinh, Janeth, Yokose, Chio, Choi, Hyon, Abhishek, Abhishek, Terkeltaub, Robert, and FitzGerald, John

Subjects
Calcium Pyrophosphate, Chondrocalcinosis, Crystal Arthropathies, Humans, Knee Joint, Wrist Joint
Abstract

OBJECTIVE: Classification criteria for calcium pyrophosphate deposition (CPPD) disease will facilitate clinical research on this common crystalline arthritis. Our objective was to report on the first 2 phases of a 4-phase process for developing CPPD classification criteria. METHODS: CPPD classification criteria development is overseen by a 12-member steering committee. Item generation (phase I) included a scoping literature review of 5 literature databases and contributions from a 35-member combined expert committee and 2 patient research partners. Item reduction and refinement (phase II) involved a combined expert committee meeting, discussions among clinical, imaging, and laboratory advisory groups, and an item-rating exercise to assess the influence of individual items toward classification. The steering committee reviewed the modal rating score for each item (range -3 [strongly pushes away from CPPD] to +3 [strongly pushes toward CPPD]) to determine items to retain for future phases of criteria development. RESULTS: Item generation yielded 420 items (312 from the literature, 108 from experts/patients). The advisory groups eliminated items that they agreed were unlikely to distinguish between CPPD and other forms of arthritis, yielding 127 items for the item-rating exercise. Fifty-six items, most of which had a modal rating of +/- 2 or 3, were retained for future phases. As numerous imaging items were rated +3, the steering committee recommended focusing on imaging of the knee and wrist and 1 additional affected joint for calcification suggestive of CPP crystal deposition. CONCLUSION: A data- and expert-driven process is underway to develop CPPD classification criteria. Candidate items comprise clinical, imaging, and laboratory features.

Published
2022

6. The gout epidemic in French Polynesia: a modelling study of data from the Ma’i u’u epidemiological survey

Author

Pascart, Tristan, Wasik, Kaja A, Preda, Cristian, Chune, Valérie, Torterat, Jérémie, Prud’homme, Nicolas, Nassih, Maryline, Martin, Agathe, Le Masson, Julien, Rodière, Vahinetua, Frogier, Sylvain, Canova, Georges, Pescheux, Jean-Paul, Shan Sei Fan, Charles, Jauffret, Charlotte, Claeys, Patrick, von Baeyer, Sarah LeBaron, Castel, Stephane E, Emde, Anne-Katrin, Yerges-Armstrong, Laura, Fox, Keolu, Leask, Megan, Vitagliano, Jean-Jacques, Graf, Sahara, Norberciak, Laurène, Raynal, Jacques, Dalbeth, Nicola, Merriman, Tony, Bardin, Thomas, and Oehler, Erwan

Published
2024
Full Text
View/download PDF

7. Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial

Author

Pascart, Tristan, Robinet, Pierre, Ottaviani, Sébastien, Leroy, Rémi, Segaud, Nicolas, Pacaud, Aurore, Grandjean, Agathe, Luraschi, Hélène, Rabin, Thibault, Deplanque, Xavier, Maciejasz, Pierre, Visade, Fabien, Mackowiak, Alexandre, Baclet, Nicolas, Maréchaux, Sylvestre, Lefebvre, Antoine, Budzik, Jean-François, Bardin, Thomas, Richette, Pascal, Norberciak, Laurène, Ducoulombier, Vincent, and Houvenagel, Eric

Published
2023
Full Text
View/download PDF

9. Les auteurs

Author

Bardin, Thomas, primary, Cohen-Solal, Martine, additional, Dieudé, Philippe, additional, Funck-Brentano, Thomas, additional, Lioté, Frédéric, additional, Richette, Pascal, additional, Adedjouma, Adenike, additional, Ascione, Sophia, additional, Assadourian, Marina, additional, Beaudreuil, Johann, additional, Benattar, Leslie, additional, Blandin, Camille, additional, Bousson, Valérie, additional, Burger, Carole, additional, Chavoix, Chantal, additional, Chopin, Clément, additional, Debiais, Françoise, additional, Ea, Hang Korng, additional, Ebstein, Esther, additional, Ferenczi, Antoine, additional, Forien, Marine, additional, Frazier-Mironer, Aline, additional, Gauffenic, Alan, additional, Jacob, Louis, additional, Jaulerry, Sarah, additional, Jousse, Marylène, additional, Juge, Pierre-Antoine, additional, Karras, Alexandre, additional, Laredo, Jean-Denis, additional, Latourte, Augustin, additional, Léger, Bastien, additional, Maillet, Jérémy, additional, Marcelli, Christian, additional, Morardet, Laetitia, additional, Nocturne, Gaetane, additional, Odri, Guillaume-Anthony, additional, Ottaviani, Sébastien, additional, Perrot, Serge, additional, Prati, Clément, additional, Razakarivony, Andrisoa Ny Ilo, additional, Simon, Virginie, additional, Taihi, Lokmane, additional, Terrier, Benjamin, additional, Vanjak, Arnaud, additional, Verhoeven, Frank, additional, Wendling, Daniel, additional, and Yoon, Diane Ji Yun, additional

Published
2023
Full Text
View/download PDF

11. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

Author

Bursill, David, Taylor, William J, Terkeltaub, Robert, Abhishek, Abhishek, So, Alexander K, Vargas-Santos, Ana Beatriz, Gaffo, Angelo Lino, Rosenthal, Ann, Tausche, Anne-Kathrin, Reginato, Anthony, Manger, Bernhard, Sciré, Carlo, Pineda, Carlos, van Durme, Caroline, Lin, Ching-Tsai, Yin, Congcong, Albert, Daniel Arthur, Biernat-Kaluza, Edyta, Roddy, Edward, Pascual, Eliseo, Becce, Fabio, Perez-Ruiz, Fernando, Sivera, Francisca, Lioté, Frédéric, Schett, Georg, Nuki, George, Filippou, Georgios, McCarthy, Geraldine, da Rocha Castelar Pinheiro, Geraldo, Ea, Hang-Korng, De Almeida Tupinambá, Helena, Yamanaka, Hisashi, Choi, Hyon K, Mackay, James, ODell, James R, Mellado, Janitzia Vázquez, Singh, Jasvinder A, Fitzgerald, John D, Jacobsson, Lennart TH, Joosten, Leo, Harrold, Leslie R, Stamp, Lisa, Andrés, Mariano, Gutierrez, Marwin, Kuwabara, Masanari, Dehlin, Mats, Janssen, Matthijs, Doherty, Michael, Hershfield, Michael S, Pillinger, Michael, Edwards, N Lawrence, Schlesinger, Naomi, Kumar, Nitin, Slot, Ole, Ottaviani, Sebastien, Richette, Pascal, MacMullan, Paul A, Chapman, Peter T, Lipsky, Peter E, Robinson, Philip, Khanna, Puja P, Gancheva, Rada N, Grainger, Rebecca, Johnson, Richard J, Kampe, Ritch Te, Keenan, Robert T, Tedeschi, Sara K, Kim, Seoyoung, Choi, Sung Jae, Fields, Theodore R, Bardin, Thomas, Uhlig, Till, Jansen, Tim, Merriman, Tony, Pascart, Tristan, Neogi, Tuhina, Klück, Viola, Louthrenoo, Worawit, and Dalbeth, Nicola

Subjects
Arthritis, Inflammatory and immune system, Consensus, Gout, Humans, Hyperuricemia, Terminology as Topic, gout, hyperuricemia, language, monosodium urate crystals, nomenclature, terminology, urate, Clinical Sciences, Immunology, Public Health and Health Services, Arthritis & Rheumatology
Abstract

ObjectiveThere is a lack of standardisation in the terminology used to describe gout. The aim of this project was to develop a consensus statement describing the recommended nomenclature for disease states of gout.MethodsA content analysis of gout-related articles from rheumatology and general internal medicine journals published over a 5-year period identified potential disease states and the labels commonly assigned to them. Based on these findings, experts in gout were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach agreement on disease state labels and definitions.ResultsThe content analysis identified 13 unique disease states and a total of 63 unique labels. The Delphi exercise (n=76 respondents) and face-to-face meeting (n=35 attendees) established consensus agreement for eight disease state labels and definitions. The agreed labels were as follows: 'asymptomatic hyperuricaemia', 'asymptomatic monosodium urate crystal deposition', 'asymptomatic hyperuricaemia with monosodium urate crystal deposition', 'gout', 'tophaceous gout', 'erosive gout', 'first gout flare' and 'recurrent gout flares'. There was consensus agreement that the label 'gout' should be restricted to current or prior clinically evident disease caused by monosodium urate crystal deposition (gout flare, chronic gouty arthritis or subcutaneous tophus).ConclusionConsensus agreement has been established for the labels and definitions of eight gout disease states, including 'gout' itself. The Gout, Hyperuricaemia and Crystal-Associated Disease Network recommends the use of these labels when describing disease states of gout in research and clinical practice.

Published
2019

12. The shrinking toe sign in gout

Author

Bardin, Thomas, Nguyen, Quang D., Hieu, Nghia L., Tran, Khoi M., Dalbeth, Nicola, Do, Minh D., Ea, Hang-Korng, Richette, Pascal, Resche-Rigon, Matthieu, and Bousson, Valérie

Published
2022
Full Text
View/download PDF

14. Current practices and access to cardiac bone scans for the detection of transthyretin cardiac amyloidosis based on the results of a large national electronic survey

Author

Hyafil, Fabien, primary, Oghina, Silvia, primary, Legallois, Damien, primary, Amara, Walid, primary, Andres, Emmanuel, primary, Bardin, Thomas, primary, Fournier, Pauline, primary, Guignard, Sandra, primary, Labeyrie, Céline, primary, Toulza, Olivier, primary, Tresorier, Romain, primary, Piriou, Nicolas, primary, SABOURET, Pierre, primary, Stanbury, Trevor, primary, Canali, Giorgia, primary, DUBOIS, Margaux, primary, Noirot-Cosson, Charlotte, primary, Rudant, Jeremie, primary, Bouquillon, Benoit, primary, Sauvage, Cedric, primary, Charron, Philippe, primary, and Damy, Thibaud, primary

Published
2024
Full Text
View/download PDF

15. Evaluating the current physicians’ knowledge and patients’ pathways for diagnosing transthyretin cardiac amyloidosis (ATTR-CM) in France: An extensive survey of diverse medical specialists.

Author

Oghina, Silvia, primary, Legallois, Damien, primary, Hyafil, Fabien, primary, Amara, Walid, primary, Andres, Emmanuel, primary, Bardin, Thomas, primary, Fournier, Pauline, primary, Guignard, Sandra, primary, Labeyrie, Céline, primary, Piriou, Nicolas, primary, SABOURET, Pierre, primary, Toulza, Olivier, primary, Tresorier, Romain, primary, Stanbury, Trevor, primary, Canali, Giorgia, primary, DUBOIS, Margaux, primary, Noirot-Cosson, Charlotte, primary, Rudant, Jeremie, primary, Bouquillon, Benoit, primary, Sauvage, Cedric, primary, Charron, Philippe, primary, and Damy, Thibaud, primary

Published
2024
Full Text
View/download PDF

17. Les auteurs

Author

Bardin, Thomas, primary, Cohen-Solal, Martine, additional, Dieudé, Philippe, additional, Funck-Brentano, Thomas, additional, Lioté, Frédéric, additional, Richette, Pascal, additional, Arnaud, Laurent, additional, Ascione, Sophia, additional, Assadourian, Marina, additional, Avouac, Jérôme, additional, Beaudreuil, Johann, additional, Blandin, Camille, additional, Bourrat, Emmanuelle, additional, Bousson, Valérie, additional, Bouvard, Béatrice, additional, Chafai, Karima, additional, Chevalier, Xavier, additional, Chotard, Émilie, additional, Ea, Hang Korng, additional, Ebstein, Esther, additional, Eymard, Florent, additional, Fabre, Stéphanie, additional, Ferenczi, Antoine, additional, Forien, Marine, additional, Frazier-Mironer, Aline, additional, Gauffenic, Alan, additional, Gautier, Jean-François, additional, Guignard, Sandra, additional, Hoppé, Emmanuel, additional, Jacob, Louis, additional, Jaulerry, Sarah, additional, Juge, Pierre-Antoine, additional, Lekpa, Fernando Kemta, additional, Laloi-Michelin, Marie, additional, Laredo, Jean Denis, additional, Latourte, Augustin, additional, Léger, Bastien, additional, Legrand, Erick, additional, Miceli-Richard, Corinne, additional, Moraux, Antoine, additional, Nachef, Clément, additional, Odri, Guillaume, additional, Ottaviani, Sébastien, additional, Paccou, Julien, additional, Pham, Chinh Nghia, additional, Piat, Christophe, additional, Prati, Clément, additional, Simon, Virginie, additional, Verhoeven, Frank, additional, and Wendling, Daniel, additional

Published
2022
Full Text
View/download PDF

21. Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.

Author

Hang-Korng Ea, Kischkel, Brenda, Chirayath, Twinu Wilson, Klück, Viola, Aparicio, Caroline, Hoang-Uyen Loeung, Manivet, Philippe, Jansen, Tim, Zarka, Mylène, Lioté, Frédéric, Latourte, Augustin, Bardin, Thomas, Gauffenic, Alan, Vicaut, Eric, Crișan, Tania Octavia, Netea, Mihai G., Richette, Pascal, and Joosten, Leo A. B.

Published
2024
Full Text
View/download PDF

30. Efficacité et sécurité de l’anakinra dans la goutte associée à une insuffisance rénale chronique de stade 4 ou 5 ou à une transplantation rénale : étude rétrospective multicentrique

Author

Loustau, Clotilde, Rosine, Nicolas, Forien, Marine, Ottaviani, Sébastien, Juge, Pierre-Antoine, Lioté, Frédéric, Bardin, Thomas, Richette, Pascal, Dieudé, Philippe, Richez, Christophe, Bannwarth, Bernard, Schaeverbeke, Thierry, Ea, Hang-Korng, and Truchetet, Marie-Elise

Published
2019
Full Text
View/download PDF

34. Préconisations pour la réalisation des infiltrations épidurales rachidiennes de corticostéroïdes élaborées sous l’égide de la section « rachis » reconnue par la Société française de rhumatologie, de la section « imagerie et rhumatologie interventionnelle » de la Société française de rhumatologie

Author

Marty, Marc, Bard, Hervé, Rozenberg, Sylvie, Baudens, Guy, Chevalier, Xavier, Bardin, Thomas, Fautrel, Bruno, Rannou, François, Senbel, Eric, and Laredo, Jean Denis

Published
2018
Full Text
View/download PDF

36. Efficacité et tolérance du fébuxostat chez 73 patients goutteux avec une insuffisance rénale chronique stade 4/5 : étude rétrospective de 10 centres

Author

Juge, Pierre-Antoine, Truchetet, Marie-Elise, Pillebout, Evangeline, Ottaviani, Sébastien, Vigneau, Cécile, Loustau, Clotilde, Cornec, Divi, Pascart, Tristan, Snanoudj, Renaud, Bailly, Florian, Gall, Emilie Cornec-Le, Schaeverbeke, Thierry, Saraux, Alain, Dieudé, Philippe, Flipo, René-Marc, Richette, Pascal, Lioté, Frédéric, Bardin, Thomas, Chalès, Gérard, and Ea, Hang-Korng

Published
2018
Full Text
View/download PDF

39. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers

Author

Juge, Pierre-Antoine, Truchetet, Marie-Elise, Pillebout, Evangeline, Ottaviani, Sébastien, Vigneau, Cécile, Loustau, Clotilde, Cornec, Divi, Pascart, Tristan, Snanoudj, Renaud, Bailly, Florian, Cornec-Le Gall, Emilie, Schaeverbeke, Thierry, Saraux, Alain, Dieudé, Philippe, Flipo, René-Marc, Richette, Pascal, Lioté, Frédéric, Bardin, Thomas, Chalès, Gérard, and Ea, Hang-Korng

Published
2017
Full Text
View/download PDF

42. Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene.

Author

Bardin, Thomas, Ducrot, Yves-Marie, Nguyen, Quang, Letavernier, Emmanuel, Zaworski, Jeremy, Ea, Hang-Korng, Touzain, Fréderic, Do, Minh Duc, Colot, Julien, Barguil, Yann, Biron, Antoine, Resche-Rigon, Matthieu, Richette, Pascal, and Collet, Corinne

Subjects
*GOUT diagnosis, *HYPERURICEMIA, *AFRICANS, *MELANESIANS, *SEQUENCE analysis, *GENETIC mutation, *HUMAN genome, *GENETIC variation, *LACTATE dehydrogenase, *ENZYME-linked immunosorbent assay, *DESCRIPTIVE statistics, *RESEARCH funding, *GOUT
Abstract

Objectives To investigate whether the lactate dehydrogenase D (LDHD) gene deficiency causes juvenile-onset gout. Methods We used whole-exome sequencing for two families and a targeted gene-sequencing panel for an isolated patient. d- lactate dosages were analysed using ELISA. Results We demonstrated linkage of juvenile-onset gout to homozygous carriage of three rare distinct LDHD variants in three different ethnicities. In a Melanesian family, the variant was (NM_153486.3: c.206C>T; rs1035398551) and, as compared with non-homozygotes, homozygotes had higher hyperuricaemia (P  = 0.02), lower fractional clearance of urate (P  = 0.002), and higher levels of d -lactate in blood (P  = 0.04) and urine (P  = 0.06). In a second, Vietnamese, family, very severe juvenile-onset gout was linked to homozygote carriage of an undescribed LDHD variant (NM_153486.3: c.1363dupG) leading to a frameshift followed by a stop codon, p.(AlaGly432fsTer58). Finally, a Moroccan man, with early-onset and high d -lactaturia, whose family was unavailable for testing, was homozygous for another rare LDHD variant [NM_153486.3: c.752C>T, p.(Thr251Met)]. Conclusion Rare, damaging LDHD variants can cause autosomal recessive early-onset gout, the diagnosis of which can be suspected by measuring high d -lactate levels in the blood and/or urine. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

43. List of Contributors

Author

Andrés, Mariano, primary, Bardin, Thomas, additional, Bernal, José A., additional, Blanco, Boris A., additional, Chapman, Peter T., additional, Clarson, Lorna, additional, Dalbeth, Nicola, additional, Doherty, Michael, additional, Doyle, Anthony, additional, Edwards, N. Lawrence, additional, Gaffo, Angelo L., additional, Igel, Talia F., additional, Krasnokutsky, Svetlana, additional, Mandell, Brian F., additional, Martinon, Fabio, additional, Merriman, Tony R., additional, Birger Morillon, Melanie, additional, Pascual, Eliseo, additional, Perez-Ruiz, Fernando, additional, Pillinger, Michael H., additional, Roddy, Edward, additional, Saag, Kenneth G., additional, Singh, Jasvinder A., additional, Sivera, Francisca, additional, Stamp, Lisa, additional, and Toprover, Michael, additional

Published
2019
Full Text
View/download PDF

45. New Susceptibility Locus for Rheumatoid Arthritis Suggested by a Genome-Wide Linkage Study

Author

Cornelis, Francois, Faure, Sabine, Martinez, Maria, Fritz, Pierre, Dib, Colette, Alves, Helena, Barrera, Pilar, De Vries, Niek, Balsa, Alejandro, Pascual-Salcedo, Dora, Maenaut, Kristin, Westhovens, Rene, Migliorini, Paola, Tran, Tuyet-Hoa, Delaye, Arnaud, Prince, Nathalie, Lefevre, Caroline, Thomas, Gaelle, Poirier, Murielle, Soubigou, Stephane, Alibert, Olivier, Lasbleiz, Sandra, Fouix, Sylvaine, Bouchier, Christiane, Liote, Frederic, Loste, Marie-Noelle, Lepage, Virginia, Charron, Dominique, Gyapay, Gabor, Lopes-Vaz, Antonio, Kuntz, Daniel, Bardin, Thomas, and Weissenbach, Jean

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results